CA1176160A - Compose pharmaceutique de pro-insuline humaine - Google Patents

Compose pharmaceutique de pro-insuline humaine

Info

Publication number
CA1176160A
CA1176160A CA000409922A CA409922A CA1176160A CA 1176160 A CA1176160 A CA 1176160A CA 000409922 A CA000409922 A CA 000409922A CA 409922 A CA409922 A CA 409922A CA 1176160 A CA1176160 A CA 1176160A
Authority
CA
Canada
Prior art keywords
human proinsulin
proinsulin
insulin
human
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000409922A
Other languages
English (en)
Inventor
Ronald E. Chance
Bruce H. Frank
John A. Galloway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1176160A publication Critical patent/CA1176160A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA000409922A 1981-08-27 1982-08-23 Compose pharmaceutique de pro-insuline humaine Expired CA1176160A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29675281A 1981-08-27 1981-08-27
US296,752 1981-08-27

Publications (1)

Publication Number Publication Date
CA1176160A true CA1176160A (fr) 1984-10-16

Family

ID=23143402

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000409922A Expired CA1176160A (fr) 1981-08-27 1982-08-23 Compose pharmaceutique de pro-insuline humaine

Country Status (21)

Country Link
JP (1) JPS5846023A (fr)
AU (1) AU552054B2 (fr)
BE (1) BE894186A (fr)
CA (1) CA1176160A (fr)
CH (1) CH650677A5 (fr)
DE (1) DE3232036A1 (fr)
FR (1) FR2511866B1 (fr)
GB (1) GB2104380B (fr)
HU (1) HU193522B (fr)
IE (1) IE53829B1 (fr)
IL (1) IL66610A (fr)
IT (1) IT1153184B (fr)
LU (1) LU84358A1 (fr)
MW (1) MW3782A1 (fr)
MY (1) MY8700757A (fr)
NL (1) NL8203316A (fr)
NZ (1) NZ201683A (fr)
PH (1) PH18716A (fr)
SE (1) SE8204871L (fr)
ZA (1) ZA826157B (fr)
ZW (1) ZW17382A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3576120D1 (de) * 1984-06-09 1990-04-05 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung.
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
ES2331342B1 (es) * 2006-05-22 2010-10-13 Consejo Superior Investg.Cientificas Uso de la proinsulina para la elaboracion de una composicion farmaceutica neuroprotectora, composicion terapeutica que la contiene y sus aplicaciones.
USD1010056S1 (en) * 2020-08-25 2024-01-02 Magpul Industries Corp. Gun sight

Also Published As

Publication number Publication date
NZ201683A (en) 1985-08-16
PH18716A (fr) 1985-09-11
IL66610A (en) 1985-11-29
GB2104380B (en) 1984-12-05
LU84358A1 (fr) 1983-02-28
BE894186A (fr) 1983-02-24
IT1153184B (it) 1987-01-14
MY8700757A (en) 1987-12-31
ZW17382A1 (en) 1982-11-17
CH650677A5 (de) 1985-08-15
ZA826157B (en) 1984-04-25
SE8204871D0 (sv) 1982-08-25
JPS5846023A (ja) 1983-03-17
IE822062L (en) 1983-02-27
IE53829B1 (en) 1989-03-15
SE8204871L (sv) 1983-02-28
AU8759582A (en) 1983-03-03
IL66610A0 (en) 1982-12-31
FR2511866B1 (fr) 1986-08-14
IT8223019A0 (it) 1982-08-27
DE3232036A1 (de) 1983-03-10
HU193522B (en) 1987-10-28
NL8203316A (nl) 1983-03-16
FR2511866A1 (fr) 1983-03-04
GB2104380A (en) 1983-03-09
AU552054B2 (en) 1986-05-22
MW3782A1 (en) 1984-06-13

Similar Documents

Publication Publication Date Title
Orth et al. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.
US4652548A (en) Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
AU624595B2 (en) Method for treating and preventing secondary effects of hyperinsulinemia and for treating type 2 diabetes, obesity and hyperlipidemia by application of insulin-like growth factor (IGF I)
US5374620A (en) Growth-promoting composition and its use
CA1176161A (fr) Composes pharmaceutiques contenant de l'insuline humaine et de la proinsuline
US4654324A (en) Human proinsulin pharmaceutical formulations
HU229868B1 (en) Process for producing a pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
CA1176158A (fr) Compose pharmaceutique contenant de l'insuline humaine et un c-peptide humain
JPH02101022A (ja) 糖尿病治療用医薬組成物
US5466670A (en) Use of IGF-1
CA1176160A (fr) Compose pharmaceutique de pro-insuline humaine
Westermeyer et al. Fall in blood sugar from anterior pituitary extract
CA1176159A (fr) Compose pharmaceutique contenant de l'insuline humaine, un c-peptide et de la pro-insuline
US6303127B1 (en) Treatment of disease states
KR20220039790A (ko) FGF21 Fc 융합 단백질, GLP-1 Fc 융합 단백질 및 이들의 조합 치료제와 용도
AU8510891A (en) Treatment of human lactation failure
EP0055885A2 (fr) Préparations insuliniques
WO1997012631A1 (fr) Medicament pour ameliorer la fonction renale
WO1998041222A1 (fr) Formulations de proteine de l'obesite
JPS59175437A (ja) 高コレステロ−ル血症改善剤
JPH0827024A (ja) 口腔粘膜疾患治療剤

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry